Patents by Inventor Kai Treuner

Kai Treuner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
    Publication number: 20110319386
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: June 10, 2011
    Publication date: December 29, 2011
    Applicant: BrainCells Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kai Treuner, Michael Lee
  • NEUROGENESIS BY MODULATING ANGIOTENSIN
    Publication number: 20110269717
    Abstract: The instant invention describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulating angiotensin activity to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: November 30, 2010
    Publication date: November 3, 2011
    Applicant: BrainCells Inc.
    Inventors: Carrolee BARLOW, Todd A. Carter, Kai Treuner, Kym I. Lorrain, Corey R. Seehus
  • Combinations containing a 4-acylaminopyridine derivative
    Patent number: 7998971
    Abstract: The instant disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system. The disclosure includes compositions and methods based on use of a 4-acylaminopyridine derivative in combination with one or more other neurogenic agents. One 4-acylaminopyridine derivative is MKC-231.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: August 16, 2011
    Assignee: BrainCells Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • Modulation of neurogenesis by PDE inhibition
    Patent number: 7985756
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a PDE agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: July 26, 2011
    Assignee: BrainCells Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Kai Treuner
  • NEUROGENESIS BY MODULATING ANGIOTENSIN
    Publication number: 20110092464
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulating angiotensin activity to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: December 20, 2010
    Publication date: April 21, 2011
    Applicant: BrainCells Inc.
    Inventors: Carolee BARLOW, Todd A. Carter, Kai Treuner, Kym I. Lorrain
  • MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS
    Publication number: 20110046090
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a GABA agent or GABA analog, in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 24, 2011
    Applicant: BrainCells Inc.
    Inventors: Carrolee BARLOW, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain, Jammieson Pires
  • Neurogenesis by modulating angiotensin
    Patent number: 7858611
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulation angiotensin activity to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: December 28, 2010
    Assignee: BrainCells Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kai Treuner, Kym I. Lorrain
  • MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS
    Publication number: 20100216734
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use nootropic agents, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: November 19, 2009
    Publication date: August 26, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain, Dana Gitnick, Jammieson C. Pires
  • MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS
    Publication number: 20100216805
    Abstract: The disclosure provides compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure provides compositions and methods based on the use of D-cycloserine in combination with the neurogenic agent, which synergistically stimulates or activates the formation of new nerve cells.
    Type: Application
    Filed: February 24, 2010
    Publication date: August 26, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym Lorrain
  • MODULATION OF NEUROGENESIS BY PPAR AGENTS
    Publication number: 20100184806
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of a peroxisome proliferator-activated receptor (PPAR) agent, optionally in combination with one or more neurogenic agents, to stimulate or increase a neurogenic response and/or to treat a nervous system disease or disorder.
    Type: Application
    Filed: January 20, 2010
    Publication date: July 22, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym Lorrain
  • NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION
    Publication number: 20100120842
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: January 22, 2010
    Publication date: May 13, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
  • 5 HT receptor mediated neurogenesis
    Patent number: 7678808
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: March 16, 2010
    Assignee: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
    Patent number: 7678363
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on muscarinic receptor modulation, such as via inhibition of acetylcholine esterase (AChE) activity, alone or in combination with another neurogenic agent to stimulate or activate the formation of new nerve cells.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: March 16, 2010
    Assignee: BrainCells Inc
    Inventors: Carrolee Barlow, Todd A. Carter, Kym I. Lorrain, Jammieson C. Pires, Andrew Morse, Dana Gitnick, Kai Treuner, Alex Broadhead
  • 5 HT RECEPTOR MEDIATED NEUROGENESIS
    Publication number: 20100009983
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, in combination with one or more other neurogenic agents, or anti-astrogenic agent, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: June 25, 2009
    Publication date: January 14, 2010
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • 5 HT RECEPTOR MEDIATED NEUROGENESIS
    Publication number: 20090325949
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: June 25, 2009
    Publication date: December 31, 2009
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • MCC-257 MODULATION OF NEUROGENESIS
    Publication number: 20090239834
    Abstract: The disclosure provides methods and a composition for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of (5-acetamido-N-(5alpha-cholestan-3alpha-yl)-3,5-dideoxy-2-O-methyl-D-glycero-alpha-D-galacto-non-2-ulopyranosonamide(MCC-257).
    Type: Application
    Filed: March 23, 2009
    Publication date: September 24, 2009
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • ALISKIREN MODULATION OF NEUROGENESIS
    Publication number: 20090197823
    Abstract: The disclosure provides compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of a renin inhibitor in combination with one or more neurogenic agents. The disclosure also includes compositions and methods for stimulating or activating the formation of new nerve cells based on the application of a renin inhibitor in combination with one or more neurogenic agents.
    Type: Application
    Filed: March 23, 2009
    Publication date: August 6, 2009
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
    Publication number: 20080188457
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of one or more biguanides in combination with one or more GSK3-? agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: February 1, 2008
    Publication date: August 7, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • Modulation Of Neurogenesis With Use of Modafinil
    Publication number: 20080171750
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of modafinil, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: January 10, 2008
    Publication date: July 17, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carrolee Barlow, Todd A. Carter, Andrew Morse, Kai Treuner, Kym I. Lorrain
  • NEUROGENESIS BY MODULATING ANGIOTENSIN
    Publication number: 20080167291
    Abstract: The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulation angiotensin activity to stimulate or activate the formation of new nerve cells.
    Type: Application
    Filed: May 9, 2007
    Publication date: July 10, 2008
    Applicant: BrainCells, Inc.
    Inventors: Carolee Barlow, Todd A. Carter, Kai Treuner, Kym I. Lorrain